10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · page 7 of 27
The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.
Deck · other · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 3/3
list 1/1 table 1/1 title 1/1
Components 3
bullet data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.